Linda Glennie, Head of Research at Meningitis Research Foundation explained, “This new research could be game-changing and merits further investigation. It could ultimately add weight to the argument for vaccinating teenagers here in the UK with the MenB vaccine, especially since gonorrhoea has become increasingly resistant to antibiotics in the UK and around the world.
Meningococcal B infection has for decades been the largest cause of life-threatening meningitis in the UK. Introducing the Bexsero vaccine for babies in 2015 was a major step forward, but teenagers are a high risk age group for the disease too. We are also funding research to help show whether vaccinating teenagers could help stop spread of the MenB bacteria to others, which would add further weight to the case for a teenage MenB vaccine.”